AARP: Keeping your home healthy before, during and after caregiver visits

UC expert offers tips on staying sanitary when a caregiver visits

AARP interviewed Dr. Carl Fichtenbaum of UC's Division of Infectious Diseases for a story on how to maintain a sanitary environment in your home before, during and after a visit from a caregiver.

Professor Carl J. Fichtenbaum, MD shown here his in lab at MSB. UC/ Joseph Fuqua UC/Joseph Fuqua II

Dr. Carl Fichtenbaum in a lab in the Division of Infectious Diseases at the UC College of Medicine. Photo credit/Joe Fuqua II/UC Creative + Brand

Dr. Fichtenbaum says older adults should first check with caretakers and aides through their home care company if they have a policy of screening staff for COVID-19 symptoms or exposure each day prior to a visit.

"If you hire someone directly, call them the day before and ask about symptoms like fever, cough, sneezing or runny nose," says Dr. Fichtenbaum. "Ask if they have been exposed to someone with COVID-19 in the past two weeks. If yes to either, it's probably best to avoid the visit." 

Read the entire article here

Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.

Related Stories

1

Tips to avoid headaches this holiday season

December 15, 2025

A University of Cincinnati migraine expert offered a list of potential headache triggers around the holidays, and how you can try to avoid them, to 91.7 WVXU News. "There are a number of different factors that make this a very headache provocative time," said Vincent Martin, MD, professor of clinical medicine at the University of Cincinnati's College of Medicine and director of the Headache and Facial Pain Center at the Gardner Neuroscience Institute.

3

New combination treatment improves multiple myeloma outcomes

December 11, 2025

The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.